HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation.

Abstract
Tissue factor (TF), the cellular receptor and cofactor for factor VII/VIIa, initiates haemostasis and thrombosis. Initial tissue distribution studies suggested that TF was sequestered from the circulation and only present at perivascular sites. However, there is now clear evidence that TF also exists as a blood-borne form with critical contributions not only to arterial thrombosis following plaque rupture and to venous thrombosis following endothelial perturbation, but also to various other clotting abnormalities associated with trauma, infection, or cancer. Because thrombin generation, fibrin deposition, and platelet aggregation in the contexts of haemostasis, thrombosis, and pathogen defence frequently occur without TF de novo synthesis, considerable efforts are still directed to understanding the molecular events underlying the conversion of predominantly non-coagulant or cryptic TF on the surface of haematopoietic cells to a highly procoagulant molecule following cellular injury or stimulation. This article will review some of the still controversial mechanisms implicated in cellular TF activation or decryption with particular focus on the coordinated effects of outer leaflet phosphatidylserine exposure and thiol-disulfide exchange pathways involving protein disulfide isomerase (PDI). In this regard, our recent findings of ATP-triggered stimulation of the purinergic P2X7 receptor on myeloid and smooth muscle cells resulting in potent TF activation and shedding of procoagulant microparticles as well as of rapid monocyte TF decryption following antithymocyte globulin-dependent membrane complement fixation have delineated specific PDI-dependent pathways of cellular TF activation and thus illustrated additional and novel links in the coupling of inflammation and coagulation.
AuthorsFlorian Langer, Wolfram Ruf
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 111 Issue 4 Pg. 590-7 (Apr 01 2014) ISSN: 2567-689X [Electronic] Germany
PMID24452853 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Antilymphocyte Serum
  • Receptors, Purinergic P2X7
  • Thromboplastin
  • Carboxy-Lyases
  • phosphatidylserine decarboxylase
  • Protein Disulfide-Isomerases
Topics
  • Animals
  • Antilymphocyte Serum (metabolism)
  • Blood Coagulation (drug effects)
  • Carboxy-Lyases (metabolism)
  • Complement Activation
  • Drug Synergism
  • Humans
  • Inflammation (blood)
  • Myeloid Cells (metabolism)
  • Myocytes, Smooth Muscle (metabolism)
  • Protein Disulfide-Isomerases (metabolism)
  • Receptors, Purinergic P2X7 (metabolism)
  • Thromboplastin (metabolism)
  • Thrombosis (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: